Neurological Device Market Size, Share and Trends Analysis | Global | 2026-2032 | MedSuite | Includes: Neuromodulation Devices, Detachable Coils, Liquid Embolics, and 10 more

Product Description

Overall, the global neurological device market was valued at $12.2 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.1% to reach $16.1 billion.

The full report suite on the global market for neurological devices includes cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular catheters, neurovascular guidewires, neurovascular stents, balloon occlusion devices, aneurysm clips, neurovascular thrombus management, neuromodulation devices, intrathecal pumps, stereotactic devices and ultrasonic aspiration devices.

The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

Data Types Included

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2032, and Historical Data to 2022
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

Global Neurological Device Market Trends

Emerging markets and technologies are increasingly shaping the neurological devices market, with artificial intelligence and machine learning enhancing diagnostic precision and procedural efficiency through advanced imaging analysis and predictive modeling. These tools enable earlier detection of neurological conditions and support more personalized treatment approaches. At the same time, augmented and virtual reality are improving both neurosurgical training and intraoperative navigation by providing real-time, three-dimensional visualization of patient anatomy, leading to greater surgical accuracy and improved outcomes. In parallel, cloud-based neuroimaging platforms are streamlining data management and enabling seamless collaboration across healthcare facilities, allowing for faster diagnoses, remote consultations and more coordinated care, particularly when integrated with AI-driven analytics.

Global Neurological Device Market Share Insights

• Medtronic holds the leading position in the global neurological device market in 2025, supported by its broad and well-diversified portfolio across multiple segments. The company demonstrates particularly strong dominance in areas such as cerebrospinal fluid management, liquid embolics, intrathecal pumps and stereotactic devices, while also maintaining a leading presence in neuromodulation and neurovascular stents. In addition, Medtronic competes effectively in thrombus management and detachable coils, reinforcing its position across both therapeutic and interventional applications. This extensive coverage, combined with its ability to maintain strong positions in several high-value segments, enables Medtronic to sustain its overall market leadership and competitive advantage globally.
• Stryker holds the second-leading position in the global neurological device market in 2025, driven by its strong presence in neurovascular and stroke-related interventions. The company demonstrates leadership in segments such as neurovascular guidewires and ultrasonic aspiration, while also maintaining a competitive position in areas including detachable coils, balloon occlusion, neurovascular stents and thrombus management. Stryker’s portfolio is heavily focused on interventional solutions, allowing it to capitalize on the growing demand for minimally invasive procedures. This targeted strength across key neurovascular segments supports its solid overall position as a major competitor in the global market.
• Boston Scientific ranks as the third-leading competitor in the global neurological device market in 2025, largely supported by its strong presence in the neuromodulation segment. The company has advanced beyond its earlier Precision™ systems, expanding its spinal cord stimulation portfolio with more sophisticated platforms such as WaveWriter Alpha and Spectra WaveWriter, which offer multi-waveform capabilities and enhanced programming for personalized therapy. While its portfolio remains primarily concentrated in neuromodulation, ongoing technological enhancements—including MRI compatibility and integrated digital features—strengthen its competitive position and allow it to maintain a leading standing in the overall market despite relatively narrower segment diversification.

Global Neurological Device Market Segmentation Summary

• Cerebrospinal Fluid (CSF) Management Market – Further Segmented Into:
  • Device Type: CSF Shunt, and CSF External Drainage System.
• Detachable Coil Market – Further Segmented Into:
  • Material Type: Bare Platinum, and Coated.
• Liquid Embolic Market
• Neurovascular Guidewire Market
• Neurovascular Catheter Market – Further Segmented Into:
  • Device Type: Over-the-Wire Microcatheter, Flow-Directed Microcatheter, and Neurovascular Guiding Catheter.
• Neurovascular Stent Market – Further Segmented Into:
  • Device Type: Traditional Neurovascular Stent, Flow Diversion Stent, and Intrasaccular Stent.
• Balloon Occlusion Device Market
• Aneurysm Clip Market – Further Segmented Into:
  • Material Type: Titanium, and Cobalt Alloy.
  • Device Modality: Temporary, and Permanent.
• Neurovascular Thrombus Management Market – Further Segmented Into:
  • Device Type: Stent Retriever, Aspiration Catheter, and Aspiration Pump Canister.
• Neuromodulation Device Market – Further Segmented Into:
  • Device Type: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Gastric Electric Stimulation.
• Intrathecal Pump Market
• Stereotactic Device Market – Further Segmented Into:
  • Device Type: Frame-Based, and Frameless.
• Ultrasonic Aspirator Market – Further Segmented Into:
  • Device Type: Capital Equipment, Disposable Probe Tip, Disposable Tubing, Handpiece, and Accessories.

Research Scope Summary